#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15586	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2456	772.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1919	1919	T	1008	T,G,C	1005,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15586	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2456	772.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1653	1653	C	1053	C,A	1051,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26278	23S	2890	2890	99.9	23S.l6.c30.ctg.1	4019	815.1	0	.	n	.	0	C543T	SNP	543	543	C	1091	1091	T	1027	T,C,G	1025,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26278	23S	2890	2890	99.9	23S.l6.c30.ctg.1	4019	815.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1885	1885	A	1133	A	1133	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26278	23S	2890	2890	99.9	23S.l6.c30.ctg.1	4019	815.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2519	2519	C	946	C	946	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26278	23S	2890	2890	99.9	23S.l6.c30.ctg.1	4019	815.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2593	2593	A	858	A	858	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26278	23S	2890	2890	99.9	23S.l6.c30.ctg.1	4019	815.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3145	3145	C	967	C,A,G	964,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	539	2368	folP	855	855	99.88	folP.l15.c4.ctg.1	1930	153.0	1	SNP	p	R229S	1	R229S	NONSYN	685	687	CGC	1205	1207	AGC	258;256;256	A;G;C,A	258;256;255,1	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5432	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3731	181.3	0	.	p	.	0	V290I	NONSYN	868	870	GTT	1381	1383	ATT	220;220;220	A,G;T;T	219,1;220;220	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5432	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3731	181.3	1	SNP	p	S91F	0	.	.	271	273	TCC	784	786	TCC	211;211;211	T;C;C	211;211;211	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5432	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3731	181.3	1	SNP	p	D95G	0	.	.	283	285	GAC	796	798	GAC	212;217;217	G;A;C	212;217;217	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5432	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3731	181.3	1	SNP	p	D95N	0	.	.	283	285	GAC	796	798	GAC	212;217;217	G;A;C	212;217;217	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	2132	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1657	160.1	1	SNP	p	G45D	1	.	.	133	135	GAC	653	655	GAC	254;256;256	G;A;C	254;256;256	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1136	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	1433	99.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5158	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3301	194.5	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1660	1662	ATC	274;273;275	A;T;C,A	274;273;274,1	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5158	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3301	194.5	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1813	1815	GCA	255;256;254	G;C;A	255;256;254	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5158	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3301	194.5	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2296	2298	ATT	258;256;254	A;T,G;T	258;255,1;254	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5158	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3301	194.5	1	SNP	p	D86N	0	.	.	256	258	GAC	766	768	GAC	227;227;224	G;A;C	227;226;224	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5158	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3301	194.5	1	SNP	p	S87I	0	.	.	259	261	AGT	769	771	AGT	225;226;228	A;G;T	225;226;228	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5158	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3301	194.5	1	SNP	p	S87R	0	.	.	259	261	AGT	769	771	AGT	225;226;228	A;G;T	225;226;228	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5158	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3301	194.5	1	SNP	p	S87W	0	.	.	259	261	AGT	769	771	AGT	225;226;228	A;G;T	225;226;228	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5158	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3301	194.5	1	SNP	p	S88P	0	.	.	262	264	TCC	772	774	TCC	231;232;233	T;C;C	231;232;233	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4268	parE	1986	1986	99.95	parE.l6.c4.ctg.1	3008	176.5	0	.	p	.	0	H611N	NONSYN	1831	1833	CAC	2272	2274	AAC	221;222;222	A;A,T,G,C;C,T	221;219,1,1,1;221,1	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4268	parE	1986	1986	99.95	parE.l6.c4.ctg.1	3008	176.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1669	1671	GGC	261;261;263	G;G,C;C	261;260,1;263	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	0	.	p	.	0	A438V	NONSYN	1312	1314	GCA	1884	1886	GTC	280;281;283	G;T,G;C	280;280,1;283	.	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	0	.	p	.	0	V444E	NONSYN	1330	1332	GTT	1902	1904	GAA	272;276;274	G;A,C;A	272;275,1;274	.	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	0	.	p	.	0	L448V	NONSYN	1342	1344	CTC	1914	1916	GTC	279;278;279	G;T;C	279;278;279	.	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	0	.	p	.	0	Q458K	NONSYN	1372	1374	CAA	1944	1946	AAA	267;268;268	A;A;A	267;268;268	.	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	0	.	p	.	0	I462V	NONSYN	1384	1386	ATA	1956	1958	GTC	273;273;272	G;T;C	273;273;272	.	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	0	.	p	.	0	F463I	NONSYN	1387	1389	TTC	1959	1961	ATC	271;269;266	A;T;C,T	271;269;265,1	.	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	0	.	p	.	0	E465A	NONSYN	1393	1395	GAA	1965	1967	GCC	266;264;265	G,T;C,T;C	265,1;263,1;265	.	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	0	.	p	.	0	R469K	NONSYN	1405	1407	CGC	1977	1979	AAA	249;249;247	A;A;A	249;248;246	.	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	0	.	p	.	0	E470K	NONSYN	1408	1410	GAG	1980	1982	AAA	248;251;251	A;A;A	247;250;250	.	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	0	.	p	.	0	N473E	NONSYN	1417	1419	AAT	1989	1991	GAG	245;246;244	G;A;G	245;246;244	.	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	0	.	p	.	0	N513Y	NONSYN	1537	1539	AAC	2109	2111	TAC	198;199;201	T;A;C,A	198;199;200,1	.	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	0	.	p	.	0	G517A	NONSYN	1549	1551	GGT	2121	2123	GCC	209;212;212	G;C,T;C	209;211,1;212	.	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	0	.	p	.	0	A550T	NONSYN	1648	1650	GCA	2220	2222	ACA	251;251;251	A,G;C;A,C	250,1;251;250,1	.	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1503	1505	GCA	267;266;264	G;C;A	267;266;264	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1506	1508	ATC	266;266;269	A,C;T;C	265,1;266;269	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1518	1520	GTG	269;269;269	G;T,A;G	269;268,1;269	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1518	1520	GTG	269;269;269	G;T,A;G	269;268,1;269	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2076	2078	GCG	201;201;202	G;C,G;G,T	201;199,2;201,1	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2076	2078	GCG	201;201;202	G;C,G;G,T	201;199,2;201,1	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2199	2201	GGT	255;250;252	G;G;T,C	255;250;250,2	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2208	2210	GGC	249;248;252	G;G;C	249;248;252	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	539	4392	penA	1752	1752	95.66	penA.l15.c4.ctg.1	2901	189.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2226	2228	CCG	255;257;258	C;C,T,A;G,C	255;255,1,1;257,1	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5920	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3458	213.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2596	porA	1146	1146	99.65	porA.l15.c17.ctg.1	2148	150.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	678	678	C	211	C	211	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	354	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	367	38.8	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	37;38;41	T;T;A	37;38;41	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	354	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	367	38.8	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	70;70;70	C;A;T	70;70;70	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	354	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	367	38.8	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	70;70;70	A;G;T	70;70;70	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	354	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	367	38.8	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	70;71;71	T;A;C	70;71;71	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	354	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	367	38.8	0	.	p	.	0	R307E	NONSYN	919	921	AGA	161	163	GAA	3;3;3	G;A;A	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	354	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	367	38.8	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	3;3;3	G;C;A	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	354	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	367	38.8	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	4;4;4	A;T;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	354	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	367	38.8	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	5;5;5	T;C;G	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	354	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	367	38.8	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	5;5;5	G;C;C	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	354	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	367	38.8	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	4;4;4	A;G;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	354	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	367	38.8	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	4;4;4	G;C;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	354	porB1a	984	226	90.71	porB1a.l15.c4.ctg.1	367	38.8	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	5;5;5	G;T;T	5;5;5	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3378	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1763	235.4	0	.	p	.	0	R143G	NONSYN	427	429	AGA	842	844	GGA	291;294;296	G,C;G,C;A,G	290,1;293,1;295,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3378	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1763	235.4	0	.	p	.	0	.	INDELS	629	630	AA	1045	1047	TAG	270;274;274	T,A;A,C;G	269,1;273,1;274	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3378	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1763	235.4	0	.	p	.	0	.	MULTIPLE	631	633	TAC	1049	1052	CAAT	269;274;276;275	C,T;A;A;T	268,1;274;276;275	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3378	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1763	235.4	0	.	p	.	0	N212fs	FSHIFT	634	634	A	1054	1054	T	274	T	274	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3378	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1763	235.4	1	SNP	p	G120K	0	.	.	358	360	GGT	773	775	GGT	275;275;277	G,T;G;T	273,2;275;277	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3378	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1763	235.4	1	SNP	p	A121N	0	.	.	361	363	GCC	776	778	GCC	275;275;274	G;C;C	275;275;274	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3378	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1763	235.4	1	SNP	p	A121D	0	.	.	361	363	GCC	776	778	GCC	275;275;274	G;C;C	275;275;274	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11318	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5364	263.2	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2219	2221	CAT	323;318;317	C;A;T	323;318;317	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1538	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1289	147.9	1	SNP	p	V57M	0	.	.	169	171	GTG	663	665	GTG	283;287;290	G;T;G	283;287;290	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
